Burden, epidemiology, and outcomes of microbiologically confirmed respiratory viral infections in solid organ transplant recipients: a nationwide, multi-season prospective cohort study.

Mombelli, Matteo; Lang, Brian M; Neofytos, Dionysios; Aubert, John-David; Benden, Christian; Berger, Christoph; Boggian, Katia; Egli, Adrian; Soccal, Paola M; Kaiser, Laurent; Hirzel, Cédric; Pascual, Manuel; Koller, Michael; Mueller, Nicolas J; van Delden, Christian; Hirsch, Hans H; Manuel, Oriol (2021). Burden, epidemiology, and outcomes of microbiologically confirmed respiratory viral infections in solid organ transplant recipients: a nationwide, multi-season prospective cohort study. American journal of transplantation, 21(5), pp. 1789-1800. Wiley-Blackwell 10.1111/ajt.16383

[img]
Preview
Text
ajt.16383 (5).pdf - Accepted Version
Available under License Publisher holds Copyright.

Download (13MB) | Preview

Solid organ transplant (SOT) recipients are exposed to respiratory viral infection (RVI) during seasonal epidemics; however, the associated burden of disease has not been fully characterized. We describe the epidemiology and outcomes of RVI in a cohort enrolling 3294 consecutive patients undergoing SOT from May 2008 to December 2015 in Switzerland. Patient and allograft outcomes, and RVI diagnosed during routine clinical practice were prospectively collected. Median follow-up was 3.4 years (interquartile range 1.61-5.56). Six-hundred-ninety-six RVI were diagnosed in 151/334 (45%) lung and 265/2960 (5%) non-lung transplant recipients. Cumulative incidence was 60% (95% confidence interval [CI] 53%-69%) in lung and 12% (95% CI 11%-14%) in non-lung transplant recipients. RVI led to 17.9 (95% CI 15.7-20.5) hospital admissions per 1000 patient-years. Intensive care unit admission was required in 4% (27/691) of cases. Thirty-day all-cause case fatality rate was 0.9% (6/696). Using proportional hazard models we found that RVI (adjusted-hazard ratio [aHR] 2.45; 95% CI 1.62-3.73), lower respiratory tract RVI (aHR 3.45; 95% CI 2.15-5.52), and influenza (aHR 3.57; 95% CI 1.75-7.26) were associated with graft failure or death. In this cohort of SOT recipients, RVI caused important morbidity and may affect long-term outcomes, underlying the need for improved preventive strategies.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology

UniBE Contributor:

Hirzel, Cédric

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1600-6135

Publisher:

Wiley-Blackwell

Language:

English

Submitter:

Annelies Luginbühl

Date Deposited:

09 Dec 2020 16:56

Last Modified:

02 Nov 2021 00:25

Publisher DOI:

10.1111/ajt.16383

PubMed ID:

33131188

BORIS DOI:

10.7892/boris.148174

URI:

https://boris.unibe.ch/id/eprint/148174

Actions (login required)

Edit item Edit item
Provide Feedback